Consistent with those findings, our data showed that fascin expression in breast cancer cells, which enhances invasion, suppresses BRMS1 and counteract its effect on downstream targets by increasing NF-κB activity, uPA secretion and MMP enzymatic activity. This evidence concerns the gene FSCN1 and breast carcinoma.